The Latest Headlines at American Banking and Market News
Fastenal (NASDAQ:FAST) Given New $64.00 Price Target at HSBC
Fastenal (NASDAQ:FAST – Free Report) had its target price hoisted by HSBC from $59.00 to $64.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a hold rating on the stock. FAST... More of this article »
Extreme Networks (NASDAQ:EXTR) Upgraded by B. Riley to Buy
B. Riley upgraded shares of Extreme Networks (NASDAQ:EXTR – Free Report) from a neutral rating to a buy rating in a report released on Monday, MarketBeat reports. They currently have $14.00 price target on the technology company’s... More of this article »
4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Increased to $40.00 by Analysts at Royal Bank of Canada
4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price objective raised by Royal Bank of Canada from $35.00 to $40.00 in a research note issued to investors on Monday, Benzinga reports. They currently have an outperform... More of this article »
Charter Communications (NASDAQ:CHTR) Given New $297.00 Price Target at Rosenblatt Securities
Charter Communications (NASDAQ:CHTR – Free Report) had its price objective reduced by Rosenblatt Securities from $334.00 to $297.00 in a report issued on Monday morning, Benzinga reports. They currently have a neutral rating... More of this article »
Dollar Tree (NASDAQ:DLTR) Price Target Increased to $152.00 by Analysts at JPMorgan Chase & Co.
Dollar Tree (NASDAQ:DLTR – Free Report) had its price objective increased by JPMorgan Chase & Co. from $144.00 to $152.00 in a research note published on Monday, Benzinga reports. JPMorgan Chase & Co. currently has... More of this article »
Cisco Systems (NASDAQ:CSCO) Upgraded to Buy at Bank of America
Bank of America upgraded shares of Cisco Systems (NASDAQ:CSCO – Free Report) from a neutral rating to a buy rating in a report published on Monday, MarketBeat.com reports. Bank of America currently has $60.00 price target on... More of this article »
Churchill Downs (NASDAQ:CHDN) Upgraded to “Overweight” by Wells Fargo & Company
Wells Fargo & Company upgraded shares of Churchill Downs (NASDAQ:CHDN – Free Report) from an equal weight rating to an overweight rating in a research note released on Monday, Marketbeat Ratings reports. They currently have... More of this article »
Community West Bancshares (NASDAQ:CWBC) Price Target Increased to $24.00 by Analysts at Piper Sandler
Community West Bancshares (NASDAQ:CWBC – Free Report) had its price objective hoisted by Piper Sandler from $22.00 to $24.00 in a report issued on Monday morning, Benzinga reports. They currently have an overweight rating on... More of this article »
CleanSpark’s (CLSK) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of CleanSpark (NASDAQ:CLSK – Free Report) in a research report report published on Monday morning, Benzinga reports. They currently have a $27.00 price target on the stock. Several... More of this article »
Diamondback Energy (NASDAQ:FANG) Given New $184.00 Price Target at Morgan Stanley
Diamondback Energy (NASDAQ:FANG – Free Report) had its price target decreased by Morgan Stanley from $186.00 to $184.00 in a research note released on Monday, Benzinga reports. Morgan Stanley currently has an overweight rating... More of this article »
Alto Ingredients, Inc. (NASDAQ:ALTO) Short Interest Update
Alto Ingredients, Inc. (NASDAQ:ALTO – Get Free Report) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 1,310,000 shares, a drop of 14.4% from the March 15th... More of this article »
Credo Technology Group (NASDAQ:CRDO) Given New $30.00 Price Target at Craig Hallum
Credo Technology Group (NASDAQ:CRDO – Free Report) had its target price increased by Craig Hallum from $28.00 to $30.00 in a report published on Monday morning, Benzinga reports. Craig Hallum currently has a buy rating on the... More of this article »
4D Molecular Therapeutics (NASDAQ:FDMT) Receives New Coverage from Analysts at Barclays
Barclays initiated coverage on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a research note issued to investors on Monday morning, Marketbeat reports. The brokerage issued an overweight rating on the stock. Several... More of this article »